Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0H5GP
|
|||
Drug Name |
PMID29671355-Compound-15
|
|||
Drug Type |
Small molecular drug
|
|||
Structure |
Download2D MOL |
|||
Formula |
C17H22N2O5
|
|||
Canonical SMILES |
C1CN(CC2=C(C=C(C=C2)C(=O)NO)OC1)C(=O)C3CCOCC3
|
|||
InChI |
1S/C17H22N2O5/c20-16(18-22)13-2-3-14-11-19(6-1-7-24-15(14)10-13)17(21)12-4-8-23-9-5-12/h2-3,10,12,22H,1,4-9,11H2,(H,18,20)
|
|||
InChIKey |
UIDRHDHNNBIRIS-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Histone deacetylase 6 (HDAC6) | Target Info | Inhibitor | [1] |
Target's Patent Info | Histone deacetylase 6 (HDAC6) | Target's Patent Info | [1] | |
KEGG Pathway | Alcoholism | |||
Viral carcinogenesis | ||||
Pathway Interaction Database | Signaling events mediated by HDAC Class II | |||
Signaling events mediated by HDAC Class I | ||||
Reactome | NOTCH1 Intracellular Domain Regulates Transcription | |||
Constitutive Signaling by NOTCH1 PEST Domain Mutants | ||||
Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | ||||
Assembly of the primary cilium | ||||
WikiPathways | Ectoderm Differentiation | |||
Neural Crest Differentiation | ||||
Cell Cycle |
References | Top | |||
---|---|---|---|---|
REF 1 | HDAC inhibitors: a 2013-2017 patent survey.Expert Opin Ther Pat. 2018 Apr 19:1-17. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.